Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 12, 1997
Issued Date -
N/A
app pub date -
May 19, 1995
filing date -
Mar 17, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising the administration to the patient of a pharmaceutically effective amount of a pharmaceutical composition containing, in admixture with a pharmaceutically acceptable carrier, a compound, or a pharmaceutically acceptable salt thereof, of the formula ##STR1## wherein the radicals are defined in the specification.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully